![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.00 | -0.27% | 1,122.00 | 1,125.50 | 1,126.50 | 1,132.00 | 1,121.00 | 1,123.00 | 3,601,342 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3008 | 37.42 | 9.84B |
Date | Subject | Author | Discuss |
---|---|---|---|
28/7/2022 10:16 | ian, the bigger discrepancy between it and competitors and esp if pound stays weak the bigger the chance of m&a. but remember the shark needs to offer a premium to the 12 month price. i think anyone bidding for it wont want to pay more than 14/15 pounds so they may be happy to wait this one out. if the shares were to fall under 950 it could see a move to 600 thats just purely technical. | ![]() roguetraderuk | |
28/7/2022 10:13 | if you convert to pounds (analysts were expecting about $750m ni so about 615m pounds) and knock 50m off net income it gets you 575 for full year and with a mktcap of just over 9bn you are on about 16 and a half for this year. | ![]() roguetraderuk | |
28/7/2022 10:04 | Should have read ortho as in orthopaedics!!! | ![]() ianood | |
28/7/2022 10:03 | I think this companies mgt is pretty useless and still trying to sort the ongoing orthodox issues. Must be ripe for the likes of Spyker to consider? | ![]() ianood | |
28/7/2022 09:47 | Can't see previous FY earnings estimates being achieved as SN now appear to be guiding lower on margin for the full year ?. | ![]() essentialinvestor | |
28/7/2022 09:44 | it was seen as pretty defensive so maybe thats why it never got to single fig pe. presently they are 17/16/15 times current and next which doesnt quite put them in the value hunter camp so theres no need to go overboard here. ive been trying to leg in and out, maintaining a position but keeping the avg going down, i presently own an eighth possie from 1125 so not keen on adding at present. nick train mentioned these a bit higher up but made it clear he wasnt interested at those prices. i think below 10 pounds a few people will start to look at them. | ![]() roguetraderuk | |
28/7/2022 08:22 | i have mentioned this margin issue on china before. i was surprised no analysts looked at it over the past few months. hence the "surprise" today. since china implemented zero covid its essentially put sn supply china issues in that zone into a semi permanent state. its quite poss they continue with this for a few years, so you are going to have tough comps on this issue til the end of the year now. so you are having to set back equilibrium towards the end of the year. areas of past support are around 1050 and there is a lt gap at 965. the former is quite poss and i wouldnt rule out the latter if the general mkt softens. | ![]() roguetraderuk | |
28/7/2022 08:17 | Just as well you didn't! The half year report seems to be similar to all the other large multinationals , so in that sense the Market cannot really be surprised that the revenues are up but the margins are narrower from the the various headwinds. I suspect most of us are long term holders and won't make much of it , just hold and forget. | ![]() wad collector | |
27/7/2022 17:39 | * Luck to holders for tomorrow - should have added. Kept this on a watch list. | ![]() essentialinvestor | |
27/7/2022 17:35 | I sold a few at £12.08 bought on Monday, so expect it to now rocket on the update. tomorrow!. | ![]() essentialinvestor | |
27/7/2022 17:22 | At least we're past the 1200's EI. | ![]() keyno | |
22/7/2022 14:19 | Looking limper than a vicar's handshake atm. | ![]() essentialinvestor | |
20/7/2022 12:25 | interim results next week, can't believe how quiet it is here........ | ![]() chrisdgb | |
16/6/2022 11:42 | renewed china issues should be affecting them but recent results have shown they have turned their own particular execution corner. its called elective surgey but really its not something you put off, so that business should see business regardless of what is happening elsewhere. the covid lows reached a band of sup that EI mentioned and i think that would be a great level to look at or ad. i presently hold a quarter possie in this and looking for lower levels to add to it. i want to see the mkt on its knees first as despite recent losses, its still a bit too orderly. | ![]() roguetraderuk | |
15/6/2022 15:54 | I agree PD looks a no brainer but seems to stubbornly sit at these low levels. It's weird so much optimism baked into airline shares say, but not here. Patience hopefully will pay off. | ![]() jrr774 | |
15/6/2022 15:47 | I doubled my holding in this one earlier today. It makes no sense for SN/ to be trading 2% above the COVID trough when electives were cancelled etc. | ![]() pdosullivan | |
29/4/2022 15:41 | Stuck this back on a watch list, update relatively encouraging. | ![]() essentialinvestor | |
29/4/2022 09:45 | Oops..wrong page ? | ![]() mansell59 | |
29/4/2022 09:44 | Bid rumours? | ![]() mansell59 | |
29/4/2022 09:09 | I bought back in around 12.63 so thank you for your comment, made me nervous to miss out | ![]() jonojubb | |
24/4/2022 10:59 | With a trading update imminent on Thursday and much to be positive about with this company I think you will be lucky to see the low 12s again, unless the general market is very poor for the first part of the week and SN. tracks it down unavoidably. I think now is time to stay invested and we could see £18 by the end of 2022 | ![]() chamer1 | |
22/4/2022 15:37 | I agree, I expect the long term to be much higher so I hope I get back in around low 12s | ![]() jonojubb | |
22/4/2022 15:30 | jnj reported strong growth in elective surgery hence the strength in the shares here. but looks like 200dma firmly rejected. what has been encouraging is that there has been no lower low than the feb low. maybe not a big deal elsewhere but for this name which has serially underperformed its a big deal. i have a half position just a few percent below current so not in a hurry to sell it but while capped by 200dma then some weakness likely. relative to index however its probably going to do a bit better. | ![]() roguetraderuk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions